Viewing Study NCT01057459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-02-17 @ 5:43 PM
Study NCT ID: NCT01057459
Status: COMPLETED
Last Update Posted: 2017-06-27
First Post: 2010-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701
Sponsor: Alliance for Clinical Trials in Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stage II Grade 1 Contiguous Follicular Lymphoma View
None Stage II Grade 1 Non-Contiguous Follicular Lymphoma View
None Stage II Grade 2 Contiguous Follicular Lymphoma View
None Stage II Grade 2 Non-Contiguous Follicular Lymphoma View
None Stage II Grade 3 Contiguous Follicular Lymphoma View
None Stage II Grade 3 Non-Contiguous Follicular Lymphoma View
None stage III grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View